Based on the ONCOMINE database analysis, we found that the SEC61G gene was highly expressed in many types of tumors, such as brain/CNS cancer, head and neck cancer, and kidney cancer, compared with its expression in normal control tissues (Fig. 1d). Here, SEC61G is linked to kidney cancer.